ABSTRACT A study was conducted to evaluate the influence of the purification of yeast cell wall (YCW) preparations on broiler performance and immunogenic and metabolic pathways under microbial challenge. A total of 240 (day old) chicks were distributed among two battery brooder units (48 pens; 5 birds/pen; 8 replicates/treatment). A basal starter diet was divided into 5 batches to create 6 dietary treatments; nonchallenge (NCh-C) and challenge (Ch-C) controls, semipurified YCW containing cytosol contents (SPYCW; 250 mg/kg), purified YCW (PYCW; 250 mg/kg), 50% purified beta-glucan (BG; 130 mg/kg), and 99.9% purified mannan-oligosaccharide (MOS; 53 mg/kg). All birds were immunocompromised with infectious bursal disease vaccine (10× the recommended dose) on day 10 and then all birds except NCh-C birds were challenged with Clostridium perfringens (Cp) (10 7 cfu/mL) via oral gavage on days 16 and 17. On day 21, tissue samples were collected from the jejunum and duodenum for analysis with chicken-specific, peptide arrays to study the influence of YCW supplementation on immune and metabolic kinase pathways. On day 16, SPYCW had significantly lower body weight (BW) and weight gain (WG) than other treatments except BG (P < 0.05). The productivity index (PI) was lower in SPYCW and BG than in NCh-C, Ch-C, and PYCW. On day 21, after the Cp challenge, NCh-C was higher than Ch-C, SPYCW, and BG in BW, WG, and PI (P = 0.03). The PI of PYCW was similar to NCh-C. The addition of purified YCW to the starter broiler diets influenced the immune and metabolic pathways in the gut. A total of 459 and 367 peptides in the duodenum and jejunum, respectively, were changed due to the Cp challenge. The YCW treatments had different degrees of influence on these peptides for both the duodenum and jejunum. These results suggest that relative purification of YCW and specific fractions of the YCW can influence broiler performance differently during microbial challenges and can alleviate the impact of these stressors.
INTRODUCTION
Antimicrobials are administered at sub-therapeutic levels to suppress the growth of pathogenic bacteria and to improve performance of farm animals. However, an increased demand to limit or ban the use of antibiotics at sub-therapeutic levels in livestock feed accelerates the need to explore versatile antibiotic alternatives. Many of these alternatives have demonstrated variable and inconsistent results relative to their influence on animal health and performance.
Yeast cell wall (YCW) of Saccharomyces cerevisiae is an alternative that has been investigated in vivo and in vitro and used commercially in animal feed. Mannan oligosaccharides (MOS) and β-glucans (BG) are the two main components of YCW that have been thought to contribute to its beneficial effects on host health and performance (Spring et al., 2000; Shao et al., 2013) . Studies have demonstrated a quadratic response to YCW in starter broiler (Fowler et al., 2015b) and laying hen performance (Hashim et al., 2013) , and a dose of 250 mg/kg is proposed to be optimum. Jahanian and Ashnagar (2015) reported that supplementation of laying hens diet with MOS improved performance, enhanced nutrient digestibility, decreased Salmonella counts, and increased Lactobacillus when hens were challenged with E. coli. Using YCW, combination of mannoprotein and BG or BG alone in broiler diets were reported to have similar effects on relative weights of 203 liver and thymus and villus morphology (Morales-Lopez et al., 2009) .
The structure of YCW is composed of the polysaccharides glucan and mannan, the latter of which links to proteins to form mannoproteins, lipids, and chitin. However, the percentage of each component varies due to differences in fermentation conditions and cultivation methods used to prepare the product. In addition, more than 600 strains of S. cerevisiae have been identified and categorized into three main groups according to their substrates for wine, beer, and bread (Legras et al., 2007) . This variation could be one of the factors contributing to the different performance outcomes that have been reported in the literature when using YCW as a prebiotic feed additive.
Challenges of foodborne pathogens in food production animals have intensified with increased use of antibiotic-free feeds. Clostridium perfringens (Cp) is a pathogen that represents a human health hazard and that causes significant damages and costs to the animal food production industry. The economic cost associated with this pathogen in livestock animals stems from its secretion of toxins, which can cause necrotic enteritis at different clinical levels, significantly impacting animal health and performance. Increased mortality, morbidity, and gut lesions are the main presentations associated with clinical necrotic enteritis. The subclinical form of necrotic enteritis, on the other hand, is characterized by performance retardation due to mal-digestion and -absorption (Yitbarek et al., 2012) . Although these characteristics of necrotic enteritis are noticeable, there are proximate mechanisms working in the background that explain the long-term changes in the host. A better understanding of these mechanisms can improve and accelerate strategies to develop new antimicrobial alternatives to counter this pathogen.
Kinomic studies have the potential to provide a better understanding of the cellular response to stimuli such as disease, condition, or treatment via a consideration of phosphorylation-mediated signal transduction (Arsenault and Kogut, 2012) . Peptide arrays examine the active kinases, which, in addition to the availability of reagents, make them better than other kinomics procedures such as mass spectrometry and antibody-based arrays (Arsenault and Kogut, 2012) . Cellular metabolic signaling using chicken species-specific peptide arrays was first introduced by Arsenault et al. (2013) to study the changes in skeletal muscle metabolism over time after Salmonella enterica serovar Typhimurium infection. Their study suggested that the metabolism of skeletal muscle is influenced by systemic effects of this pathogen via 5 -adenosine monophosphate-activated protein kinase (AMPK) phosphorylation, which can signal adenosine triphosphate (ATP) production, activity alterations, and insulin/mTOR signaling pathway disruptions, which can alter glucose metabolism (Arsenault et al., 2013) .
The purpose of this study was to evaluate the influence of different preparations of YCW on starter broiler performance and to provide more information regarding the importance of BG and MOS concentrations on prebiotic functionality. These products have different purification levels as well as different preparation techniques. Performance was evaluated by monitoring production attributes such as body weight (BW) and feed conversion ratios (FCR). Additionally, chicken-specific peptide arrays were used to help understand the underlying mechanisms of these changes in performance characteristics. 
MATERIALS AND METHODS

Experimental Design
This study was conducted to evaluate purified and semi-purified YCW preparations on the growth performance of broiler chicks during the starter period. Semi-purified YCW can have significant quantities of cytosolic contents remaining in the final product. A total of 240 Ross 308 (one-day-old) chicks were distributed among two Petersime battery brooder units (48 pens; 5 birds/pen). Six treatments were randomly assigned to pens and each treatment had 8 replicates. A basal broiler starter diet (Table 1 ) was prepared and divided into five batches that included non-challenge (NCh-C) and challenge (Ch-C) control groups, semipurified YCW (250 mg/kg; SPYCW), purified YCW (250 mg/kg; PYCW), 50% purified BG (130 mg/kg; BG), and ≥ 99.7% purified MOS (53 mg/kg; MOS). These preparations were added to the feed before pelleting. The YCW components for PYCW and SPYCW were 23.5% MOS and 23% BG. The 50% purified BG was derived from YCW and consists of 50% BG and 50% of protein and lipids with no MOS. The SPYCW, PYCW, and BG preparations were provided by PhileoLesaffre Animal Care (Milwaukee, WI), while MOS (≥ 99.7% purified from primary S. cerevisiae) was purchased from Sigma-Aldrich (St. Louis, MO). In previous studies performed by our laboratory, a dose of 250 mg/kg YCW was proposed to be optimum for starter broilers (Fowler et al., 2015b) . The YCW components were 23.5% MOS and 23% β-glucans. Therefore, 53 mg/kg of MOS and 130 mg/kg of BG (the preparation is 50% purified BG) doses were used for this study.
All birds in each of the 6 treatment groups were immunocompromised with infectious bursal disease vaccine (Schering Plough Animal Health, Millsboro, DE) on day 10. The vaccine was administered at ten times the manufacturer's recommended dose via the ocular route to immunocompromise the chicks (McReynolds et al., 2004) . On days 16 and 17, all treatments were challenged with Cp (10 7 cfu/mL, 3 ml oral gavage). Feed and water were provided ad libitum. Feed and BW were recorded on days 1, 10, 16, and 21. Phase mortality (P-Mort) was calculated on days 10, 16, and 21, and cumulative mortality (C-Mort) was calculated on days 16 and 21. Performance index (PI) was calculated as: (Fowler et al., 2015a) .
Isolation and Administration of Cp
Clostridium perfringens medium was provided by the ARS, Southern Plains Agricultural Research Center/USDA. The isolation and preparation of Cp were as described in McReynolds et al. (2004) . The Cp pathogen was a combination of four type A field isolates from three different regions (Georgia, Texas, and Virginia). These isolates were cultured individually, combined, and administered to the birds. Then, about one gram of the GI contents of birds diagnosed with necrotic enteritis was taken to an anaerobic chamber and placed onto 10 mL of liquid thioglycollate medium (Becton Dickinson Co., Sparks, MD) and incubated for 24 h at 37
• C.
Intestinal Tissue Sampling
Tissue samples from the duodenum and jejunum of three birds per treatment were collected at day 21 and sent to the Southern Plains Agriculture Research Center/USDA laboratory to conduct kinome analysis using chicken-specific peptide arrays as described by Arsenault et al. (2013) . Three birds from each treatment were euthanized with CO 2 and dissected to collect samples which were immediately flash frozen with liquid nitrogen to maintain kinase enzymatic activity and shipped to the USDA lab.
Chicken-specific Peptide Arrays
The peptide array protocol in this study was originally developed by Jalal et al. (2009) , using alterations described in Arsenault et al. (2013) . Briefly, jejunum and duodenum tissue samples were weighed to obtain a consistent 40 mg sample for the array protocol. Samples were homogenized using a hand-held Qiagen (Valencia, CA) TissueRuptor in 100 μL of lysis buffer. Following homogenization, an activation mix was added to cellular lysates which were then applied to individual, chicken-specific immunometabolism peptide arrays. Following incubation, the slides were washed, stained with Pro-Q Diamond (Invitrogen, Carlsbad, CA) phosphoprotein stain, and then destained. Array slides were scanned using a Tecan Systems (San Jose, CA) PowerScanner microarray scanner at 532 to 560 nm with a 580-nm filter to detect dye fluorescence. Intensity of the phosphorylation signal for each peptide was collected by GenePix 6.0 software (MDS).
Statistical Analysis
Body weight, weight gain (WG), phase feed-to-gain ratio (P-F:G), cumulative feed-to-gain ratio (C-F:G) and FCR data were analyzed as a one-way ANOVA using SPSS's general linear model. Pen level of the Petersime battery brooder units was used as a block to control variation among groups of experimental units and the design of the experiment was an incomplete block. Means deemed significant at P ≤ 0.05 were separated using a protected Duncan's multiple range test.
Peptide array data were analyzed as described by Arsenault et al. (2013) . Briefly, the resulting data points from the array image were normalized using variance stabilization to minimize variance due to technical factors such as random differences in staining intensity between arrays or between blocks within a single array. Note that, because the arrays were printed with triplicate peptide blocks, with three replicates per block, there are nine values for each peptide. Normalized data set comparisons between treatment and control groups were performed, calculating fold change and P values determined by conducting a one-sided paired Student t test between treatment and control values for a given peptide. The resultant fold change and significance values were then be used in optional analyses (hierarchical clustering, peptide similarity comparison). a,b Means ± SD within a row lacking a common superscript differ (P < 0.05).
1 NCh-C = non-challenged control; Ch-C = challenged control; SPYCW = semi-purified yeast cell wall (YCW) at 250 pm; PYCW = purified YCW at 250 mg/kg; BG = 50% purified β-glucan at 130 mg/kg; MOS = ≥99% purified mannan-oligosaccharides at 53 mg/kg.
2 NCh-C and Ch-C birds fed control diet, but differ on day 16 and 17 when Ch-C birds were challenged with Clostridium perfringens. BW = body weight; WG = weight gain; P-F:G = phase feed:gain; FCR = feed conversion ratio; PI = performance index; P-Mort = phase mortality. Table 3 . Effect of yeast cell wall purification on broiler performance on day 16 (pre-challenge). 1 NCh-C = non-challenged control; Ch-C = challenged control; SPYCW = semi-purified yeast cell wall (YCW) at 250 pm; PYCW = purified YCW at 250 mg/kg; BG = 50% purified β-glucan at 130 mg/kg; MOS = ≥99% purified mannan-oligosaccharides at 53 mg/kg.
2 NCh-C and Ch-C birds fed control diet, but differ on day 16 and 17 when Ch-C birds were challenged with Clostridium perfringens. P-F: G = phase feed: gain; C-F: G = cumulative feed: gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality. a-c Means ± SD within a row lacking a common superscript differ (P < 0.05). 1 NCh-Cont = non-challenged control; Ch-C = challenged control; SPYCW = semi-purified yeast cell wall (YCW) at 250 pm; PYCW = purified YCW at 250 mg/kg; BG = 50% purified β-glucan at 130 mg/kg; MOS = ≥99% purified mannan-oligosaccharides at 53 mg/kg.
2 NCh-Cont and Ch-C birds fed control diet, but differ on day 16 and 17 when Ch-C birds were challenged with Clostridium perfringens. P-F:G = phase feed: gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality.
RESULTS
This experiment was conducted to assess the influence of different YCW preparations containing different concentrations of BG or MOS on starter broiler performance in the presence of pathogenic stress. Performance data were calculated and analyzed on days 10 (pre-vaccination), 16 (pre-challenge), and 21 (postchallenge). In addition, chicken-specific peptide arrays were used to study the mechanism of these YCW products in ameliorating the impact of Cp using samples collected on day 21.
Broiler Performance
Performance results are presented in Tables 2, 3 , and 4. The 99% purified MOS treatment demonstrated a significant (P < 0.05) increase in BW and WG on day 10, pre-vaccination, with an approximately 24 to 41 g difference from all other groups. No significant differences were observed between treatments in P-F:G, or FCR. There was no mortality observed in this phase in any treatments except for two out of 40 birds deceased in the MOS group.
On day 16, after birds had been immunocompromised with a high dose of bursa vaccine, the 99% MOS treatment had significantly higher BW than the SPYCW and BG treatments. Birds in the SPYCW treatment exhibited significantly lower WG than in all other treatments except the BG treatment. The 50% BG treatment, in turn, was comparable to the MOS group, but lower than the PYCW, Ch-C, and NCh-C treatments.
Feed utilization was not efficient in the SPYCW, BG, or MOS treatments relative to other treatments. These three treatments had higher phase 2 P-F:G and cumulative feed to gain ratios than PYCW, Ch-C, and NCh-C treatments. The FCR of the MOS and BG treatments was significantly higher than in NCh-C, Ch-C, and PYCW treatments. However, no significant difference in FCR was observed among the Ch-C, NCh-C, semi-purified YCW, or purified YCW treatments. The PI, which is based on BW, FCR, and mortality, was significantly lower in SPYCW and BG groups than in Ch-C, NCh-C, and PYCW treatments. The MOS treatment was not significantly different in PI from Ch-C or PYCW, but was less than NCh-C. No mortality was recorded in phase 2 for all treatments.
On day 21, post Cp challenge, birds in the NCh-C group demonstrated significantly higher BW, WG, and PI than birds in the Ch-C group. The BW of the birds in the purified YCW and MOS groups was not significantly different from BW of NCh-C, but was significantly higher than birds in the SPYCW treatment. The BW of BG birds was significantly lower than NCh-C but was not significantly different from other treatments.
The phase 3 WG of the birds in both PYCW and MOS treatments was not significantly different from the NCh-C or all other treatments. However, the gain in BW after the Cp challenge was significantly lower in SPYCW or BG treatments versus the NCh-C group. Only the birds in the PYCW treatment demonstrated PI not significantly different from the NCh-C or other treatments. The PI of SPYCW, BG, and MOS treatments were significantly lower than the NCh-C but were not different from the Ch-C.
Chicken-specific Peptide Arrays
On day 21, tissue samples from the duodenum and jejunum were collected from three birds of each treatment to study the chicken immune and metabolic signaling pathways using chicken-specific peptide arrays. The response of metabolic pathways in the duodenum and jejunum to the Cp challenge and YCW or its components were different (Figures 1 and 2) . Figure 1 shows the clustering of kinotypes (complete kinase phosphorylation patterns) for duodenum and jejunum for each treatment. The lines connecting treatments, their relative length and distance, represent the similarities of treatments. This similarity is calculated by considering the phosphorylation signal across all 771 peptides on the array. A general clustering by tissue type is evident with various duodenal and jejunal samples clustering together. One can mine the cluster data for an indication of which treatment brings the kinotype more in line with the NCh-C (a positive outcome) or the Ch-C (a negative outcome). In the jejunum the MOS kinotype is clustered with the Ch-C. As every treatment is Cp challenged (excluding the NCh-C) this indicates that MOS does little to alter Cp signaling in the jejunum. Alternately, PYCW-treated Cp-challenged jejunum clusters with NCh-C, indicating that PYCW generates signaling in a Cp challenged jejunum most like an uninfected bird. For the duodenum samples, Ch-C clusters between, though not directly with, several treatment samples, making it unclear, from this figure at least, which is the least effective treatment. Uninfected, NCh-C duodenum clusters most closely with BG, though the BG from jejunum not duodenum. In Figure 2 we generated kinotypes by removing the signal from the respective tissue Cp challenge results. Removing this signal allowed observation of clustering based on differences between treatment and Cp challenge. This provides a clear distinction between the two tissue types, jejunum and duodenum, showing that their responses to treatments are tissue specific. In terms of individual phosphorylation events, the results demonstrate that Cp challenge changed the phosphorylation status of 367 peptides in the duodenum and 459 peptides in the jejunum of infected birds relative to NCh-C. The YCW or its components influenced changes in signaling pathways. In the duodenum, the percent of similarity coefficient (%CV) to NCh-C was 59.40% for BG, 42.78% for SPYCW, 33.97% for MOS, and 29.97% for PYCW. In the jejunum, purified YCW demonstrated higher similarity than other treatments. The CV% to NCh-C was 80.61% in purified YCW, 74.07% in semi-purified YCW, 69.06% in BG, and 52.94% in MOS treatments. The signaling pathways of MOS and BG are more similar to purified YCW (9 and 4 pathway differences, respectively) than they are to each other (17 pathway differences between MOS and BG), and the purified YCW was able to generate signaling that was not identical to either of the YCW components alone (supplemental data Table 1 ).
DISCUSSION
The Cp challenge successfully impaired starter phase broiler performance as demonstrated by BW, WG, and PI reduction in 21 day old control challenged birds (post Cp challenge). The application of YCW or its components in poultry diets has been under intense investigation using different nutritional, environmental, and pathological conditions or stresses (Ghasemian and Jahanian, 2016; Tian et al., 2016b) . The goal of these studies is to test the hypothesis that YCW or its components can be used as an alternative to the prophylactic use of antibiotics to promote growth in food production animals. The findings of this study show that purified YCW, which is a typical commercial YCW product with typical MOS and BG proportions, had no significant impact on broiler performance during the first 16 days of age under a controlled study environment. This is in agreement with the results of other researchers (M'Sadeq et al., 2015; Fowler et al., 2015b) who reported that the supplementation of YCW in broiler feed had no influence on performance in the early stages of growth in the absence of a significant stressor. However, at 21 days of age after Cp challenge, purified YCW was able alleviate the negative impact of Cp on broiler performance. Similar influence of YCW was reported in other studies when birds were subjected to other kinds of pathogenic stress (M'Sadeq et al., 2015; Fowler et al., 2015b) . By contrast, Yitbarek et al. (2012) reported that YCW did not improve BW in broiler starter birds challenged with Cp. However, their study supplemented the diet with 2,000 mg/kg of YCW. Moreover, Fowler et al. (2015b) showed that YCW has a quadratic effect on broiler performance and that doses higher than 500 mg/kg could start to negatively impair broiler performance.
The performance of starter broiler birds significantly declined starting on day 16 (postimmunocompromised), and continued on day 21 (post-pathogenic challenge). Unpublished studies conducted in our lab to evaluate the semi-purified YCW are in agreement with the outcomes of the current study.
The main polysaccharide components of YCW are BG and MOS. Previous literature has used the terms MOS or BG almost interchangeably to describe various YCW products in their research. In other words, some products previously described as MOS were not 99to 100% pure MOS. Obtaining commercial quantities of pure MOS or BG is cost prohibitive. Therefore, 99% purified MOS was obtained from Sigma to evaluate its influence on broiler performance and to understand its mechanism of action. β-glucan was provided as 50% purified from the YCW of S. cerevisiae. Both of these components were used at levels equivalent to their proportion in purified, with little to no cytosolic residue, YCW. For this study, the BW of the starter broiler birds was significantly improved when their diet was supplemented with ≥99% purified MOS on days 10 and 16. However, this increase in BW was accompanied by significant increases in P-F:G, C-F:G and FCR on day 16 and reduced PI on days 16 and 21. The addition of 130 mg/kg of BG, purified at 50% of primary YCW, to broiler diet did not improve the performance of starter broiler birds. This may indicate that additional tests of this BG enhanced (23 vs. 50%) product at various feeding levels may be warranted.
In another study (Shao et al., 2013) , BG was extracted from S. cerevisiae at 91% of the content of the extract and added to the diet of broilers infected with Salmonella. The study reported that 100 mg/kg of BG improved intestinal integrity and immunity. In addition, Salmonella colonization in the ceca and invasion into the liver were inhibited. The study also reported that BG improved the intestinal tight junction proteins in infected birds. Meanwhile, Tian et al. (2016a) reported increased BW in broilers fed a diet supplemented with 200 mg/kg of 91.5% pure yeast BG between 21 to 42 days of age and on day 42 of the study. Improved phase FCR was also reported between 13 to 21 and 21 to 42 days of age, but not in the cumulative FCR. However, no significant improvement was observed in broiler performance when birds were challenged with Cp and fed diet supplemented with 200 mg/kg BG. Nevertheless, BG improved villus height and crypt depth in challenged birds 7 days post challenge. The relative mRNA expression of endogenous antimicrobial peptides such as cathelicidin-1, cathelicidin-2, AvBD-1, AvBD-4, and AvBD-10 in the jejunum increased in BG treatment birds post Cp challenge. Moreover, the Cp count in the cecum of infected BG fed birds was decreased 14 and 21 days after challenge. This is the first time that chicken-specific peptide arrays were employed to study the influence of YCW or its components, MOS and BG, on the performance of starter broilers subjected to Cp challenge. The peptide array results demonstrated that Cp challenge impacted the immune and metabolic pathways in the intestine (supplemental data table 1). A total of 459 and 367 peptides in the jejunum and duodenum, respectively, were significantly changed due to the Cp challenge.
The YCW preparations and YCW components had different degrees of influence on these peptides and this influence was also different in each part of the intestine. Whereas MOS and BG treatments demonstrated only 52.94 and 69.06% similarity compared to NCh-C in the jejunum, PYCW and SPYCW treatments were 80.61 and 74.07%, respectively. These results agree with the clustering shown in figure 1, MOS generates a kinotype most like Ch-C, while PYCW generates a kinotype most like NCh-C. Because all groups in this study were challenged with Cp, except the uninfected control (NCh-C), any treatment that generates a response more like the negative control and less like Ch-C is restoring the tissue to a normal, uninfected signaling state.
In the case of the jejunum, our data show that PYCW clusters closest to NCh-C and generates a kinotype that is 80.61% similar to the jejunum of uninfected birds, a significantly better result than the 52.94% similarity generated by MOS. These data also agree with the performance data, showing that at day 21 PYCW was most effective at alleviating the effects of Cp. Considering that the jejunum is a major nutritional absorption site and PYCW is effective at restoring jejunum signaling to an uninfected-like state, this restoration may be the reason that PYCW reduces Cp-related performance loss.
In the duodenum studies, the similarity coefficient was less noticeable for all treatments and the BG treatment still had a higher similarity coefficient (59.40%) than MOS treatment (33.97%). In fact, BG treatment shows the most similarity to uninfected birds of any treatment at the duodenal level, generating 59.40% of the same peptide phosphorylation changes as uninfected duodenum. This indicates that BG may be the most effective treatment for restoring normal signaling in the duodenum of Cp challenged birds.
In Figure 2 , clustering was performed following the elimination of the Cp challenge signal from each of the treatment kinotypes. By removing this signal, we were able to observe clustering between treatment groups while limiting non-specific signaling events. This analysis provides a clear distinction between the two tissue types, jejunum (top) and duodenum (bottom). As we observed from the percent similarity data, and again in Figure 2 , responses to the various treatments depend on the tissue being assayed. Some additives may be more effective at eliminating Cp effects in the jejunum (PYCW) while others are more effective in the duodenum (BG).
The kinome data appear to show that PYCW was able to generate signaling that neither of the components (BG or MOS) was able to generate alone. This unique immune and metabolic signaling was also observed in the pathways generated by the YCW treatments compared to BG or MOS (supplemental data Table 1 ). These results indicate that YCW components may have synergetic effects, having a better influence on broiler performance together than each component has alone. Follow up studies will further characterize the signaling events initiated by MOS, BG, and PYCW in Cp challenged chicken gut with the goal of understanding the individual and combined signaling and response mechanisms generated by each component alone and in combination.
SUPPLEMENTARY DATA
Supplementary data are available at Poultry Science online.
